Adam Rosenberg joined Rodin in September 2015 as President and Chief Executive Officer. Adam previously co-founded a number of innovative companies in the Boston/Cambridge area, including: · Teleos Therapeutics, a biotechnology company leveraging unique insights in zebrafish chemical biology and novel high throughput screening technologies to discover new treatments for central nervous system disorders · Clean Membranes, a nanomaterials company based on MIT technology · Link Medicine, focused on developing novel disease-modifying neurodegenerative treatments · Faber Law Group, a boutique business law firm focused on the biotechnology sector Previously, Adam was a principal with Ovation Capital Partners, and has served as strategic advisor and interim executive to multiple companies in biotechnology and digital health. Adam also advised the production of A Late Quartet, a feature film starring Christopher Walken, Philip Seymour Hoffman and Catherine Keener, centered on a cellist in a world-class string quartet who is diagnosed with Parkinson’s disease. He currently serves on the Board of Directors of Adeo Health Sciences, a company focused on enabling the early introduction of allergens for infants.